Holding chambers versus nebulisers for inhaled steroids in chronic asthma

Cochrane Database of Systematic Reviews

Volumn 2009, Issue 3, 2006, Pages

  Cates, Christopher J ^a   Bestall, Janine C ^a   Adams, Nick P ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Worthing Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE; BUDESONIDE; GLUCOCORTICOID;

ADULT; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DELIVERY SYSTEM; HUMAN; META ANALYSIS; NEBULIZER; RANDOMIZED CONTROLLED TRIAL; REVIEW; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BUDESONIDE; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; NEBULIZERS AND VAPORIZERS; RANDOMIZED CONTROLLED TRIALS;

EID: 33645526317     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001491.pub2     Document Type: Article

References (27)

1. Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respiratory Medicine 1998;92(1):44-9.
2. Iqbal S, Ritson S, Prince I, Denyer J, Everard M. Drug delivery and adherence in young children. Pediatric Pulmonology 2004;37:311-7.
3. O'Reilly JF, Weir DC, Banham S, Basran GS, Boyd G, Patel KR. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?. Respiratory Medicine 1998;92(1):111-7.
4. de Blic J, Delacourt C, Le Bourgeois M, Mahut B, Ostinelli J, Caswell C, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. Journal of Allergy & Clinical Immunology 1996;98(1):14-20.
5. Higenbottam TW, Clark RA, Luksza AR, Morice AH, Bateman NT, Matthews AW, et al. The role of nebulised budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. European Journal of Clinical Research 1994;5:1-10.
6. Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Archives of Disease in Childhood 1993;68(3):356-9.
7. Kemp JP, Skoner DP, Szefler J, Walton-Bowen K, Cruz-Rivera M, Smith JA. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Annals of Allergy, Asthma and Immunology 1999;83:231-9.
8. Lodrup Carlsen KC, Nikander K, Carlsen KH. How much nebulised budesonide reaches infants and toddlers?. Archives of Disease in Childhood 1992;67(9):1077-9.
9. Mellon M. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Journal of Allergy and Clinical Immunology 1999;104:S191-9.
10. Murphy K, Noonan M, Silkoff PE, Uryniak T. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Clinical Therapeutics 2007; Vol. 29, issue 6:1013-26.
11. Otulana BA, Varma N, Bullock A, Higenbottam TW. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respiratory Medicine 1996;86(2):105-8.
12. Reid A, Murphy C, Steen HJ, McGovern V, Shields MD. Linear growth of very young asthmatic children treated with high-dose nebulized budesonide. Acta Paediatrica 1996;85(4):421-4.
13. Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. Journal of Allergy & Clinical Immunology 1998;102(5):789-96.
14. Storr J, Lenney CA, Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Archives of Disease in Childhood 1986;61(3):270-3.
15. Van Bever HP, Schuddinck L, Wojciechowski M, Stevens WJ. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatric Pulmonology 1990;9(3):177-80.
16. Vikre-Jorgensen J, Agertoft L, Pedersen S. Dose titration of nebulized budesonide in young children. Pediatric Pulmonology 1997;23(4):270-7.
17. Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. Journal of Allergy & Clinical Immunology 1998;101(4 Pt 1):464-9.
18. Webb MS, Milner AD, Hiller EJ, Henry RL. Nebulised beclomethasone dipropionate suspension. Archives of Disease in Childhood 1986;61(11):1108-10.
19. Wennergren G, Nordvall SL, Hedlin G, Moller C, Wille S, Asbrink Nilsson E. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatrica 1996;85(2):183-9.
20. Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics [In Process Citation]. Chest 1998;114(4):1022-7.
21. British Thoracic Society. The British guidelines on asthma management 1995 review and position statement. Thorax 1997;52(Suppl 1):S1-20.
22. National Asthma Education and Prevention Program. Global initiative for asthma management and prevention NHBLI/WHO workshop report. Bethesda MD: NIH/National Heart, Lung and Blood Institute 1995, issue Publication No. 95-4659.
23. Jadad AR, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
24. Guidelines for the Diagnosis and Managment of Asthma, Expert Panel Report No. 2. National Institutes of Health, Bethseda, MD 1997, issue NIH Publication No. 97-4051.
25. O'Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax 1997;52(Suppl 2):S31-44.
26. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respiratory Medicine 1992;86:105-8.
27. Szefler SJ. Clinical need for a nebulized corticosteroid. Journal of Allergy and Clinical Immunology 1999;104:S162-8.